A 0 1 0 1 O
scan 2 6 2 6 O
to 7 9 7 9 O
confirm 10 17 10 17 O
the 18 21 18 21 O
absence 22 29 22 29 O
of 30 32 30 32 O
brain 33 38 33 38 B-cancer
metastases 39 49 39 49 I-cancer
is 50 52 50 52 O
not 53 56 53 56 O
required 57 65 57 65 O

Absolute 0 8 66 74 B-clinical_variable
neutrophil 9 19 75 85 I-clinical_variable
count 20 25 86 91 I-clinical_variable
( 26 27 92 93 I-clinical_variable
ANC 27 30 93 96 I-clinical_variable
) 30 31 96 97 I-clinical_variable
< 32 33 98 99 O
1500 34 38 100 104 B-upper_bound
/ 38 39 104 105 I-upper_bound
μl 39 41 105 107 I-upper_bound

Absolute 0 8 108 116 B-clinical_variable
neutrophil 9 19 117 127 I-clinical_variable
count 20 25 128 133 I-clinical_variable
( 26 27 134 135 I-clinical_variable
ANC 27 30 135 138 I-clinical_variable
) 30 31 138 139 I-clinical_variable
≥ 32 33 140 141 O
1500 34 38 142 146 B-lower_bound
/ 38 39 146 147 I-lower_bound
μL 39 41 147 149 I-lower_bound

Active 0 6 150 156 O
or 7 9 157 159 O
untreated 10 19 160 169 O
brain 20 25 170 175 B-cancer
metastases 26 36 176 186 I-cancer
or 37 39 187 189 O
spinal 40 46 190 196 B-chronic_disease
cord 47 51 197 201 I-chronic_disease
compression 52 63 202 213 I-chronic_disease

Age 0 3 214 217 B-age
≥ 4 5 218 219 O
18 6 8 220 222 B-lower_bound
years 9 14 223 228 I-lower_bound

Any 0 3 229 232 O
of 4 6 233 235 O
the 7 10 236 239 O
following 11 20 240 249 O
cardiovascular 21 35 250 264 B-chronic_disease
events 36 42 265 271 I-chronic_disease
within 43 49 272 278 O
6 50 51 279 280 B-upper_bound
months 52 58 281 287 I-upper_bound
prior 59 64 288 293 I-upper_bound
to 65 67 294 296 O
study 68 73 297 302 O
entry 74 79 303 308 O
: 79 80 308 309 O
myocardial 81 91 310 320 B-chronic_disease
infarction 92 102 321 331 I-chronic_disease
, 102 103 331 332 O
malignant 104 113 333 342 B-chronic_disease
hypertension 114 126 343 355 I-chronic_disease
, 126 127 355 356 O
severe 128 134 357 363 O
/ 134 135 363 364 O
unstable 135 143 364 372 B-chronic_disease
angina 144 150 373 379 I-chronic_disease
, 150 151 379 380 O
symptomatic 152 163 381 392 O
congestive 164 174 393 403 B-chronic_disease
heart 175 180 404 409 I-chronic_disease
failure 181 188 410 417 I-chronic_disease
, 188 189 417 418 O
cerebral 190 198 419 427 B-chronic_disease
vascular 199 207 428 436 I-chronic_disease
accident 208 216 437 445 I-chronic_disease
, 216 217 445 446 O
or 218 220 447 449 O
transient 221 230 450 459 B-chronic_disease
ischemic 231 239 460 468 I-chronic_disease
attack 240 246 469 475 I-chronic_disease

Any 0 3 476 479 O
other 4 9 480 485 O
severe 10 16 486 492 O
acute 17 22 493 498 O
or 23 25 499 501 O
chronic 26 33 502 509 O
medical 34 41 510 517 O
or 42 44 518 520 O
psychiatric 45 56 521 532 B-chronic_disease
condition 57 66 533 542 I-chronic_disease
or 67 69 543 545 O
laboratory 70 80 546 556 O
abnormality 81 92 557 568 O
that 93 97 569 573 O
may 98 101 574 577 O
increase 102 110 578 586 O
the 111 114 587 590 O
risk 115 119 591 595 O
associated 120 130 596 606 O
with 131 135 607 611 O
study 136 141 612 617 O
participation 142 155 618 631 O
or 156 158 632 634 O
may 159 162 635 638 O
interfere 163 172 639 648 O
with 173 177 649 653 O
the 178 181 654 657 O
interpretation 182 196 658 672 O
of 197 199 673 675 O
study 200 205 676 681 O
results 206 213 682 689 O

At 0 2 690 692 O
least 3 8 693 698 O
one 9 12 699 702 B-lower_bound
lesion 13 19 703 709 B-clinical_variable
, 19 20 709 710 O
not 21 24 711 714 O
previously 25 35 715 725 O
irradiated 36 46 726 736 O
, 46 47 736 737 O
that 48 52 738 742 O
can 53 56 743 746 O
be 57 59 747 749 O
accurately 60 70 750 760 O
measured 71 79 761 769 O
at 80 82 770 772 O
baseline 83 91 773 781 O
as 92 94 782 784 O
≥ 95 96 785 786 O
10 97 99 787 789 B-lower_bound
mm 100 102 790 792 I-lower_bound
in 103 105 793 795 O
the 106 109 796 799 O
longest 110 117 800 807 O
diameter 118 126 808 816 O
( 127 128 817 818 O
except 128 134 818 824 O
lymph 135 140 825 830 B-clinical_variable
nodes 141 146 831 836 I-clinical_variable
which 147 152 837 842 O
must 153 157 843 847 O
have 158 162 848 852 O
short 163 168 853 858 O
axis 169 173 859 863 O
≥ 174 175 864 865 O
15 176 178 866 868 B-lower_bound
mm 179 181 869 871 I-lower_bound
) 181 182 871 872 O
with 183 187 873 877 O
computed 188 196 878 886 B-treatment
tomography 197 207 887 897 I-treatment
( 208 209 898 899 I-treatment
CT 209 211 899 901 I-treatment
) 211 212 901 902 I-treatment
or 213 215 903 905 O
magnetic 216 224 906 914 B-treatment
resonance 225 234 915 924 I-treatment
imaging 235 242 925 932 I-treatment
( 243 244 933 934 I-treatment
MRI 244 247 934 937 I-treatment
) 247 248 937 938 I-treatment
or 249 251 939 941 O
≥ 252 253 942 943 O
10 254 256 944 946 O
mm 257 259 947 949 O
with 260 264 950 954 O
calipers 265 273 955 963 B-treatment
by 274 276 964 966 O
clinical 277 285 967 975 B-treatment
exam 286 290 976 980 I-treatment
OR 291 293 981 983 O
At 294 296 984 986 O
least 297 302 987 992 O
one 303 306 993 996 O
lesion 307 313 997 1003 O
( 314 315 1004 1005 O
measurable 315 325 1005 1015 O
and/or 326 332 1016 1022 O
non 333 336 1023 1026 O
- 336 337 1026 1027 O
measurable 337 347 1027 1037 O
) 347 348 1037 1038 O
that 349 353 1039 1043 O
can 354 357 1044 1047 O
be 358 360 1048 1050 O
accurately 361 371 1051 1061 O
assessed 372 380 1062 1070 O
by 381 383 1071 1073 O
CT 384 386 1074 1076 O
/ 386 387 1076 1077 O
MRI 387 390 1077 1080 O
/ 390 391 1080 1081 O
plain 391 396 1081 1086 B-treatment
x 397 398 1087 1088 I-treatment
- 398 399 1088 1089 I-treatment
ray 399 402 1089 1092 I-treatment
/ 402 403 1092 1093 O
clinical 403 411 1093 1101 O
exam 412 416 1102 1106 O
at 417 419 1107 1109 O
baseline 420 428 1110 1118 O
and 429 432 1119 1122 O
follow 433 439 1123 1129 O
up 440 442 1130 1132 O
visits 443 449 1133 1139 O

Blood 0 5 1140 1145 B-treatment
( 6 7 1146 1147 I-treatment
packed 7 13 1147 1153 I-treatment
red 14 17 1154 1157 I-treatment
blood 18 23 1158 1163 I-treatment
cells 24 29 1164 1169 I-treatment
, 29 30 1169 1170 I-treatment
platelets 31 40 1171 1180 I-treatment
) 40 41 1180 1181 I-treatment
transfusions 42 54 1182 1194 I-treatment
within 55 61 1195 1201 O
1 62 63 1202 1203 B-upper_bound
month 64 69 1204 1209 I-upper_bound
prior 70 75 1210 1215 I-upper_bound
to 76 78 1216 1218 O
study 79 84 1219 1224 O
start 85 90 1225 1230 O

Concurrent 0 10 1231 1241 O
administration 11 25 1242 1256 O
of 26 28 1257 1259 O
any 29 32 1260 1263 O
other 33 38 1264 1269 O
anti 39 43 1270 1274 B-treatment
- 43 44 1274 1275 I-treatment
cancer 44 50 1275 1281 I-treatment
therapy 51 58 1282 1289 I-treatment

Eastern 0 7 1290 1297 B-clinical_variable
Cooperative 8 19 1298 1309 I-clinical_variable
Oncology 20 28 1310 1318 I-clinical_variable
Group 29 34 1319 1324 I-clinical_variable
Performance 35 46 1325 1336 I-clinical_variable
Status 47 53 1337 1343 I-clinical_variable
( 54 55 1344 1345 I-clinical_variable
ECOG 55 59 1345 1349 I-clinical_variable
PS 60 62 1350 1352 I-clinical_variable
) 62 63 1352 1353 I-clinical_variable
score 64 69 1354 1359 I-clinical_variable
of 70 72 1360 1362 O
0 73 74 1363 1364 B-lower_bound
or 75 77 1365 1367 O
1 78 79 1368 1369 B-upper_bound

Hemoglobin 0 10 1370 1380 B-clinical_variable
( 11 12 1381 1382 I-clinical_variable
Hgb 12 15 1382 1385 I-clinical_variable
) 15 16 1385 1386 I-clinical_variable
< 17 18 1387 1388 O
10 19 21 1389 1391 B-upper_bound
g 22 23 1392 1393 I-upper_bound
/ 23 24 1393 1394 I-upper_bound
dL 24 26 1394 1396 I-upper_bound

Hemoglobin 0 10 1397 1407 B-clinical_variable
( 11 12 1408 1409 I-clinical_variable
Hgb 12 15 1409 1412 I-clinical_variable
) 15 16 1412 1413 I-clinical_variable
≥ 17 18 1414 1415 O
10 19 21 1416 1418 B-lower_bound
g 22 23 1419 1420 I-lower_bound
/ 23 24 1420 1421 I-lower_bound
dL 24 26 1421 1423 I-lower_bound
( 27 28 1424 1425 O
may 28 31 1425 1428 O
be 32 34 1429 1431 O
achieved 35 43 1432 1440 O
with 44 48 1441 1445 O
erythropoietin 49 63 1446 1460 B-treatment
agents 64 70 1461 1467 I-treatment
; 70 71 1467 1468 O
no 72 74 1469 1471 O
blood 75 80 1472 1477 B-treatment
transfusions 81 93 1478 1490 I-treatment
in 94 96 1491 1493 O
the 97 100 1494 1497 O
28 101 103 1498 1500 B-upper_bound
days 104 108 1501 1505 I-upper_bound
prior 109 114 1506 1511 I-upper_bound
to 115 117 1512 1514 O
entry 118 123 1515 1520 O
) 123 124 1520 1521 O

Histologically 0 14 1522 1536 O
documented 15 25 1537 1547 O
metastatic 26 36 1548 1558 B-cancer
cancer 37 43 1559 1565 I-cancer
( 44 45 1566 1567 O
solid 45 50 1567 1572 B-cancer
tumors 51 57 1573 1579 I-cancer
, 57 58 1579 1580 O
not 59 62 1581 1584 O
including 63 72 1585 1594 O
hematologic 73 84 1595 1606 B-cancer
malignancies 85 97 1607 1619 I-cancer
) 97 98 1619 1620 O

History 0 7 1621 1628 O
of 8 10 1629 1631 O
carcinomatous 11 24 1632 1645 B-cancer
meningitis 25 35 1646 1656 I-cancer

History 0 7 1657 1664 O
or 8 10 1665 1667 O
presence 11 19 1668 1676 O
of 20 22 1677 1679 O
clinically 23 33 1680 1690 O
significant 34 45 1691 1702 O
ventricular 46 57 1703 1714 B-clinical_variable
or 58 60 1715 1717 O
atrial 61 67 1718 1724 B-clinical_variable
dysrhythmia 68 79 1725 1736 I-clinical_variable
> 80 81 1737 1738 O
Grade 82 87 1739 1744 B-lower_bound
2 88 89 1745 1746 I-lower_bound
( 90 91 1747 1748 O
NCI 91 94 1748 1751 O
CTCAE 95 100 1752 1757 O
v4.0 101 105 1758 1762 O
) 105 106 1762 1763 O

Hormonal 0 8 1764 1772 B-treatment
therapy 9 16 1773 1780 I-treatment
with 17 21 1781 1785 I-treatment
luteinizing 22 33 1786 1797 I-treatment
hormone 34 41 1798 1805 I-treatment
- 41 42 1805 1806 I-treatment
releasing 42 51 1806 1815 I-treatment
hormone 52 59 1816 1823 I-treatment
( 60 61 1824 1825 I-treatment
LHRH 61 65 1825 1829 I-treatment
) 65 66 1829 1830 I-treatment
analogues 67 76 1831 1840 O
for 77 80 1841 1844 O
medical 81 88 1845 1852 O
castration 89 99 1853 1863 O
in 100 102 1864 1866 O
patients 103 111 1867 1875 O
with 112 116 1876 1880 O
castrate 117 125 1881 1889 B-cancer
- 125 126 1889 1890 I-cancer
resistant 126 135 1890 1899 I-cancer
prostate 136 144 1900 1908 I-cancer
cancer 145 151 1909 1915 I-cancer

Immunocompromised 0 17 1916 1933 B-chronic_disease
patients 18 26 1934 1942 O
, 26 27 1942 1943 O
e.g. 28 32 1944 1948 O
, 32 33 1948 1949 O
patients 34 42 1950 1958 O
who 43 46 1959 1962 O
are 47 50 1963 1966 O
known 51 56 1967 1972 O
to 57 59 1973 1975 O
be 60 62 1976 1978 O
serologically 63 76 1979 1992 O
positive 77 85 1993 2001 O
for 86 89 2002 2005 O
human 90 95 2006 2011 B-chronic_disease
immunodeficiency 96 112 2012 2028 I-chronic_disease
virus 113 118 2029 2034 I-chronic_disease
( 119 120 2035 2036 I-chronic_disease
HIV 120 123 2036 2039 I-chronic_disease
) 123 124 2039 2040 I-chronic_disease
and 125 128 2041 2044 O
are 129 132 2045 2048 O
receiving 133 142 2049 2058 O
antiviral 143 152 2059 2068 B-treatment
therapy 153 160 2069 2076 I-treatment
( 161 162 2077 2078 O
testing 162 169 2078 2085 O
is 170 172 2086 2088 O
not 173 176 2089 2092 O
part 177 181 2093 2097 O
of 182 184 2098 2100 O
the 185 188 2101 2104 O
protocol 189 197 2105 2113 O
) 197 198 2113 2114 O

Inadequate 0 10 2115 2125 O
bone 11 15 2126 2130 O
marrow 16 22 2131 2137 O
reserve 23 30 2138 2145 O
within 31 37 2146 2152 O
past 38 42 2153 2157 O
28 43 45 2158 2160 B-upper_bound
days 46 50 2161 2165 I-upper_bound
prior 51 56 2166 2171 I-upper_bound
to 57 59 2172 2174 O
study 60 65 2175 2180 O
treatment 66 75 2181 2190 B-treatment

Life 0 4 2191 2195 B-clinical_variable
expectancy 5 15 2196 2206 I-clinical_variable
≥ 16 17 2207 2208 O
16 18 20 2209 2211 B-lower_bound
weeks 21 26 2212 2217 I-lower_bound

Major 0 5 2218 2223 B-treatment
surgery 6 13 2224 2231 I-treatment
within 14 20 2232 2238 O
3 21 22 2239 2240 B-upper_bound
weeks 23 28 2241 2246 I-upper_bound
prior 29 34 2247 2252 I-upper_bound
to 35 37 2253 2255 O
first 38 43 2256 2261 O
dose 44 48 2262 2266 O
of 49 51 2267 2269 O
study 52 57 2270 2275 B-treatment
treatment 58 67 2276 2285 I-treatment
, 67 68 2285 2286 O
and 69 72 2287 2290 O
patients 73 81 2291 2299 O
must 82 86 2300 2304 O
have 87 91 2305 2309 O
recovered 92 101 2310 2319 O
from 102 106 2320 2324 O
the 107 110 2325 2328 O
effects 111 118 2329 2336 O
of 119 121 2337 2339 O
surgery 122 129 2340 2347 O

Molecular 0 9 2348 2357 B-treatment
testing 10 17 2358 2365 I-treatment
or 18 20 2366 2368 O
appropriate 21 32 2369 2380 O
IHC 33 36 2381 2384 B-treatment
results 37 44 2385 2392 O
from 45 49 2393 2397 O
CLIA 50 54 2398 2402 O
- 54 55 2402 2403 O
certified 55 64 2403 2412 O
laboratories 65 77 2413 2425 O
used 78 82 2426 2430 O
for 83 86 2431 2434 O
patient 87 94 2435 2442 O
eligibility 95 106 2443 2454 O
should 107 113 2455 2461 O
be 114 116 2462 2464 O
obtained 117 125 2465 2473 O
from 126 130 2474 2478 O
the 131 134 2479 2482 O
most 135 139 2483 2487 O
recent 140 146 2488 2494 B-treatment
tumor 147 152 2495 2500 I-treatment
biopsy 153 159 2501 2507 I-treatment
( 160 161 2508 2509 O
baseline 161 169 2509 2517 B-treatment
tumor 170 175 2518 2523 I-treatment
biopsies 176 184 2524 2532 I-treatment
and 185 188 2533 2536 O
on 189 191 2537 2539 B-treatment
- 191 192 2539 2540 I-treatment
progression 192 203 2540 2551 I-treatment
tumor 204 209 2552 2557 I-treatment
biopsies 210 218 2558 2566 I-treatment
are 219 222 2567 2570 O
optional 223 231 2571 2579 O
) 231 232 2579 2580 O

No 0 2 2581 2583 O
features 3 11 2584 2592 O
suggestive 12 22 2593 2603 O
of 23 25 2604 2606 O
MDS 26 29 2607 2610 B-cancer
/ 29 30 2610 2611 O
AML 30 33 2611 2614 B-cancer
on 34 36 2615 2617 O
peripheral 37 47 2618 2628 B-treatment
blood 48 53 2629 2634 I-treatment
smear 54 59 2635 2640 I-treatment

No 0 2 2641 2643 O
previous 3 11 2644 2652 O
treatment 12 21 2653 2662 B-treatment
with 22 26 2663 2667 I-treatment
olaparib 27 35 2668 2676 I-treatment
or 36 38 2677 2679 O
any 39 42 2680 2683 O
other 43 48 2684 2689 O
drug 49 53 2690 2694 O
sharing 54 61 2695 2702 O
the 62 65 2703 2706 O
same 66 70 2707 2711 O
target 71 77 2712 2718 O
. 77 78 2718 2719 O
Prior 79 84 2720 2725 B-treatment
treatment 85 94 2726 2735 I-treatment
with 95 99 2736 2740 I-treatment
PARP 100 104 2741 2745 I-treatment
inhibitor 105 114 2746 2755 I-treatment
monotherapy 115 126 2756 2767 I-treatment
is 127 129 2768 2770 O
allowed 130 137 2771 2778 O
in 138 140 2779 2781 O
the 141 144 2782 2785 O
combination 145 156 2786 2797 O
arms 157 161 2798 2802 O

Patient 0 7 2803 2810 O
is 8 10 2811 2813 O
willing 11 18 2814 2821 O
and 19 22 2822 2825 O
able 23 27 2826 2830 O
to 28 30 2831 2833 O
comply 31 37 2834 2840 O
with 38 42 2841 2845 O
the 43 46 2846 2849 O
protocol 47 55 2850 2858 O
for 56 59 2859 2862 O
the 60 63 2863 2866 O
duration 64 72 2867 2875 O
of 73 75 2876 2878 O
the 76 79 2879 2882 O
study 80 85 2883 2888 O
including 86 95 2889 2898 O
undergoing 96 106 2899 2909 O
treatment 107 116 2910 2919 B-treatment
and 117 120 2920 2923 O
scheduled 121 130 2924 2933 O
visits 131 137 2934 2940 O
and 138 141 2941 2944 O
examinations 142 154 2945 2957 O
including 155 164 2958 2967 O
follow 165 171 2968 2974 O
up 172 174 2975 2977 O

Patient 0 7 2978 2985 O
must 8 12 2986 2990 O
not 13 16 2991 2994 O
have 17 21 2995 2999 O
a 22 23 3000 3001 O
co 24 26 3002 3004 O
- 26 27 3004 3005 O
morbid 27 33 3005 3011 O
condition(s 34 45 3012 3023 O
) 45 46 3023 3024 O
that 47 51 3025 3029 O
, 51 52 3029 3030 O
in 53 55 3031 3033 O
the 56 59 3034 3037 O
opinion 60 67 3038 3045 O
of 68 70 3046 3048 O
the 71 74 3049 3052 O
investigator 75 87 3053 3065 O
, 87 88 3065 3066 O
prevent 89 96 3067 3074 O
safe 97 101 3075 3079 O
treatment 102 111 3080 3089 B-treatment

Patients 0 8 3090 3098 O
considered 9 19 3099 3109 O
a 20 21 3110 3111 O
poor 22 26 3112 3116 O
medical 27 34 3117 3124 O
risk 35 39 3125 3129 O
due 40 43 3130 3133 O
to 44 46 3134 3136 O
a 47 48 3137 3138 O
serious 49 56 3139 3146 O
, 56 57 3146 3147 O
uncontrolled 58 70 3148 3160 O
medical 71 78 3161 3168 B-chronic_disease
disorder 79 87 3169 3177 I-chronic_disease
, 87 88 3177 3178 O
non 89 92 3179 3182 B-chronic_disease
- 92 93 3182 3183 I-chronic_disease
malignant 93 102 3183 3192 I-chronic_disease
systemic 103 111 3193 3201 I-chronic_disease
disease 112 119 3202 3209 I-chronic_disease
or 120 122 3210 3212 O
active 123 129 3213 3219 B-chronic_disease
, 129 130 3219 3220 O
uncontrolled 131 143 3221 3233 B-chronic_disease
infection 144 153 3234 3243 I-chronic_disease
. 153 154 3243 3244 O
Examples 155 163 3245 3253 O
include 164 171 3254 3261 O
, 171 172 3261 3262 O
but 173 176 3263 3266 O
are 177 180 3267 3270 O
not 181 184 3271 3274 O
limited 185 192 3275 3282 O
to 193 195 3283 3285 O
, 195 196 3285 3286 O
uncontrolled 197 209 3287 3299 O
ventricular 210 221 3300 3311 B-chronic_disease
arrhythmia 222 232 3312 3322 I-chronic_disease
, 232 233 3322 3323 O
superior 234 242 3324 3332 B-chronic_disease
vena 243 247 3333 3337 I-chronic_disease
cava 248 252 3338 3342 I-chronic_disease
syndrome 253 261 3343 3351 I-chronic_disease
, 261 262 3351 3352 O
extensive 263 272 3353 3362 O
bilateral 273 282 3363 3372 B-chronic_disease
lung 283 287 3373 3377 I-chronic_disease
disease 288 295 3378 3385 I-chronic_disease
on 296 298 3386 3388 O
HRCT 299 303 3389 3393 B-treatment
scan 304 308 3394 3398 I-treatment
or 309 311 3399 3401 O
any 312 315 3402 3405 O
psychiatric 316 327 3406 3417 B-chronic_disease
disorder 328 336 3418 3426 I-chronic_disease
that 337 341 3427 3431 O
prohibits 342 351 3432 3441 O
obtaining 352 361 3442 3451 O
informed 362 370 3452 3460 O
consent 371 378 3461 3468 O

Patients 0 8 3469 3477 O
must 9 13 3478 3482 O
not 14 17 3483 3486 O
have 18 22 3487 3491 O
received 23 31 3492 3500 O
allogeneic 32 42 3501 3511 B-treatment
stem 43 47 3512 3516 I-treatment
cell 48 52 3517 3521 I-treatment
transplant 53 63 3522 3532 I-treatment

Patients 0 8 3533 3541 O
must 9 13 3542 3546 O
not 14 17 3547 3550 O
have 18 22 3551 3555 O
received 23 31 3556 3564 O
these 32 37 3565 3570 O
therapies 38 47 3571 3580 B-treatment
for 48 51 3581 3584 O
21 52 54 3585 3587 B-upper_bound
days 55 59 3588 3592 I-upper_bound
or 60 62 3593 3595 O
five 63 67 3596 3600 O
half 68 72 3601 3605 O
- 72 73 3605 3606 O
lives 73 78 3606 3611 O
of 79 81 3612 3614 O
the 82 85 3615 3618 O
drug 86 90 3619 3623 O
( 91 92 3624 3625 O
whichever 92 101 3625 3634 O
is 102 104 3635 3637 O
less 105 109 3638 3642 O
) 109 110 3642 3643 O
prior 111 116 3644 3649 O
to 117 119 3650 3652 O
the 120 123 3653 3656 O
initiation 124 134 3657 3667 O
of 135 137 3668 3670 O
study 138 143 3671 3676 B-treatment
treatment 144 153 3677 3686 I-treatment
and 154 157 3687 3690 O
must 158 162 3691 3695 O
have 163 167 3696 3700 O
full 168 172 3701 3705 O
recovery 173 181 3706 3714 O
from 182 186 3715 3719 O
any 187 190 3720 3723 O
acute 191 196 3724 3729 O
clinically 197 207 3730 3740 O
significant 208 219 3741 3752 O
effects 220 227 3753 3760 O
of 228 230 3761 3763 O
these 231 236 3764 3769 O
therapies 237 246 3770 3779 O

Patients 0 8 3780 3788 O
unable 9 15 3789 3795 O
to 16 18 3796 3798 O
swallow 19 26 3799 3806 O
orally 27 33 3807 3813 B-treatment
administered 34 46 3814 3826 I-treatment
medication 47 57 3827 3837 I-treatment
and 58 61 3838 3841 O
patients 62 70 3842 3850 O
with 71 75 3851 3855 O
gastrointestinal 76 92 3856 3872 B-chronic_disease
disorders 93 102 3873 3882 I-chronic_disease
likely 103 109 3883 3889 O
to 110 112 3890 3892 O
interfere 113 122 3893 3902 O
with 123 127 3903 3907 O
absorption 128 138 3908 3918 O
of 139 141 3919 3921 O
the 142 145 3922 3925 O
study 146 151 3926 3931 B-treatment
medication 152 162 3932 3942 I-treatment

Patients 0 8 3943 3951 O
who 9 12 3952 3955 O
have 13 17 3956 3960 O
received 18 26 3961 3969 O
standard 27 35 3970 3978 O
first 36 41 3979 3984 B-treatment
- 41 42 3984 3985 I-treatment
line 42 46 3985 3989 I-treatment
therapy 47 54 3990 3997 I-treatment
for 55 58 3998 4001 O
metastatic 59 69 4002 4012 B-cancer
cancer 70 76 4013 4019 I-cancer
( 77 78 4020 4021 O
except 78 84 4021 4027 O
for 85 88 4028 4031 O
the 89 92 4032 4035 O
tumors 93 99 4036 4042 B-cancer
for 100 103 4043 4046 O
which 104 109 4047 4052 O
no 110 112 4053 4055 O
first 113 118 4056 4061 O
- 118 119 4061 4062 O
line 119 123 4062 4066 O
therapy 124 131 4067 4074 O
exists 132 138 4075 4081 O
) 138 139 4081 4082 O
and 140 143 4083 4086 O
in 144 146 4087 4089 O
whom 147 151 4090 4094 O
a 152 153 4095 4096 O
trial 154 159 4097 4102 O
of 160 162 4103 4105 O
targeted 163 171 4106 4114 B-treatment
therapy 172 179 4115 4122 I-treatment
is 180 182 4123 4125 O
considered 183 193 4126 4136 O
the 194 197 4137 4140 O
best 198 202 4141 4145 O
available 203 212 4146 4155 O
treatment 213 222 4156 4165 B-treatment
option 223 229 4166 4172 O
. 229 230 4172 4173 O
Eligible 231 239 4174 4182 O
patients 240 248 4183 4191 O
should 249 255 4192 4198 O
not 256 259 4199 4202 O
have 260 264 4203 4207 O
available 265 274 4208 4217 O
therapies 275 284 4218 4227 B-treatment
that 285 289 4228 4232 O
will 290 294 4233 4237 O
convey 295 301 4238 4244 O
clinical 302 310 4245 4253 O
benefit 311 318 4254 4261 O

Patients 0 8 4262 4270 O
with 9 13 4271 4275 O
a 14 15 4276 4277 O
known 16 21 4278 4283 O
hypersensitivity 22 38 4284 4300 O
to 39 41 4301 4303 O
olaparib 42 50 4304 4312 B-allergy_name
or 51 53 4313 4315 O
any 54 57 4316 4319 O
of 58 60 4320 4322 O
the 61 64 4323 4326 O
excipients 65 75 4327 4337 O
of 76 78 4338 4340 O
the 79 82 4341 4344 O
product 83 90 4345 4352 O

Patients 0 8 4353 4361 O
with 9 13 4362 4366 O
a 14 15 4367 4368 O
known 16 21 4369 4374 O
hypersensitivity 22 38 4375 4391 O
to 39 41 4392 4394 O
the 42 45 4395 4398 O
combination 46 57 4399 4410 B-allergy_name
/ 57 58 4410 4411 I-allergy_name
comparator 58 68 4411 4421 I-allergy_name
agent 69 74 4422 4427 I-allergy_name

Patients 0 8 4428 4436 O
with 9 13 4437 4441 O
chronic 14 21 4442 4449 O
, 21 22 4449 4450 O
rate 23 27 4451 4455 O
- 27 28 4455 4456 O
controlled 28 38 4456 4466 O
atrial 39 45 4467 4473 B-chronic_disease
arrhythmias 46 57 4474 4485 I-chronic_disease
who 58 61 4486 4489 O
do 62 64 4490 4492 O
not 65 68 4493 4496 O
have 69 73 4497 4501 O
other 74 79 4502 4507 O
cardiac 80 87 4508 4515 B-chronic_disease
abnormalities 88 101 4516 4529 I-chronic_disease

Patients 0 8 4530 4538 O
with 9 13 4539 4543 O
concomitant 14 25 4544 4555 O
use 26 29 4556 4559 O
of 30 32 4560 4562 O
drugs 33 38 4563 4568 O
, 38 39 4568 4569 O
herbal 40 46 4570 4576 B-treatment
supplements 47 58 4577 4588 I-treatment
and/or 59 65 4589 4595 O
ingestion 66 75 4596 4605 O
of 76 78 4606 4608 O
foods 79 84 4609 4614 O
known 85 90 4615 4620 O
to 91 93 4621 4623 O
strongly 94 102 4624 4632 O
modulate 103 111 4633 4641 O
CYP3A4 112 118 4642 4648 O
enzyme 119 125 4649 4655 O
activity 126 134 4656 4664 O
as 135 137 4665 4667 O
specified 138 147 4668 4677 O
in 148 150 4678 4680 O
the 151 154 4681 4684 O
drug 155 159 4685 4689 O
specific 160 168 4690 4698 O
appendix 169 177 4699 4707 O

Patients 0 8 4708 4716 O
with 9 13 4717 4721 O
hematologic 14 25 4722 4733 B-cancer
malignancies 26 38 4734 4746 I-cancer
( 39 40 4747 4748 O
includes 40 48 4748 4756 O
patients 49 57 4757 4765 O
with 58 62 4766 4770 O
myelodysplastic 63 78 4771 4786 B-cancer
syndrome 79 87 4787 4795 I-cancer
/ 87 88 4795 4796 O
acute 88 93 4796 4801 B-cancer
myeloid 94 101 4802 4809 I-cancer
leukemia 102 110 4810 4818 I-cancer
) 110 111 4818 4819 O

Patients 0 8 4820 4828 O
with 9 13 4829 4833 O
known 14 19 4834 4839 O
( 20 21 4840 4841 O
testing 21 28 4841 4848 O
is 29 31 4849 4851 O
not 32 35 4852 4855 O
part 36 40 4856 4860 O
of 41 43 4861 4863 O
the 44 47 4864 4867 O
protocol 48 56 4868 4876 O
) 56 57 4876 4877 O
active 58 64 4878 4884 O
hepatic 65 72 4885 4892 B-chronic_disease
disease 73 80 4893 4900 I-chronic_disease
( 81 82 4901 4902 O
i.e. 82 86 4902 4906 O
, 86 87 4906 4907 O
Hepatitis 88 97 4908 4917 B-chronic_disease
B 98 99 4918 4919 I-chronic_disease
or 100 102 4920 4922 I-chronic_disease
C 103 104 4923 4924 I-chronic_disease
) 104 105 4924 4925 O
due 106 109 4926 4929 O
to 110 112 4930 4932 O
risk 113 117 4933 4937 O
of 118 120 4938 4940 O
drug 121 125 4941 4945 O
interactions 126 138 4946 4958 O
with 139 143 4959 4963 O
anti 144 148 4964 4968 B-treatment
- 148 149 4968 4969 I-treatment
viral 149 154 4969 4974 I-treatment
therapy 155 162 4975 4982 I-treatment

Patients 0 8 4983 4991 O
with 9 13 4992 4996 O
known 14 19 4997 5002 O
germline 20 28 5003 5011 O
BRCA 29 33 5012 5016 O
mutations 34 43 5017 5026 O
in 44 46 5027 5029 O
breast 47 53 5030 5036 B-cancer
cancers 54 61 5037 5044 I-cancer
will 62 66 5045 5049 O
be 67 69 5050 5052 O
excluded 70 78 5053 5061 O
from 79 83 5062 5066 O
the 84 87 5067 5070 O
study 88 93 5071 5076 O
, 93 94 5076 5077 O
however 95 102 5078 5085 O
testing 103 110 5086 5093 O
is 111 113 5094 5096 O
not 114 117 5097 5100 O
required 118 126 5101 5109 O
for 127 130 5110 5113 O
inclusion 131 140 5114 5123 O
in 141 143 5124 5126 O
the 144 147 5127 5130 O
study 148 153 5131 5136 O

Patients 0 8 5137 5145 O
with 9 13 5146 5150 O
primary 14 21 5151 5158 B-cancer
CNS 22 25 5159 5162 I-cancer
malignancies 26 38 5163 5175 I-cancer

Patients 0 8 5176 5184 O
with 9 13 5185 5189 O
second 14 20 5190 5196 O
primary 21 28 5197 5204 O
cancer 29 35 5205 5211 B-cancer
, 35 36 5211 5212 O
except 37 43 5213 5219 O
: 43 44 5219 5220 O
adequately 45 55 5221 5231 O
treated 56 63 5232 5239 O
non 64 67 5240 5243 B-cancer
- 67 68 5243 5244 I-cancer
melanoma 68 76 5244 5252 I-cancer
skin 77 81 5253 5257 I-cancer
cancer 82 88 5258 5264 I-cancer
, 88 89 5264 5265 O
curatively 90 100 5266 5276 O
treated 101 108 5277 5284 O
stage 109 114 5285 5290 B-cancer
I 115 116 5291 5292 I-cancer
cancers 117 124 5293 5300 I-cancer
( 125 126 5301 5302 O
cervix 126 132 5302 5308 B-cancer
, 132 133 5308 5309 O
breast 134 140 5310 5316 B-cancer
, 140 141 5316 5317 O
colon 142 147 5318 5323 B-cancer
, 147 148 5323 5324 O
lung 149 153 5325 5329 B-cancer
, 153 154 5329 5330 O
or 155 157 5331 5333 O
prostate 158 166 5334 5342 B-cancer
as 167 169 5343 5345 O
examples 170 178 5346 5354 O
) 178 179 5354 5355 O
or 180 182 5356 5358 O
other 183 188 5359 5364 O
advanced 189 197 5365 5373 O
( 198 199 5374 5375 O
> 199 200 5375 5376 O
Stage 201 206 5377 5382 B-lower_bound
I)solid 207 214 5383 5390 I-lower_bound
tumors 215 221 5391 5397 I-cancer
curatively 222 232 5398 5408 O
treated 233 240 5409 5416 O
with 241 245 5417 5421 O
no 246 248 5422 5424 O
evidence 249 257 5425 5433 O
of 258 260 5434 5436 O
disease 261 268 5437 5444 O
for 269 272 5445 5448 O
≥ 273 274 5449 5450 O
5 275 276 5451 5452 B-lower_bound
years 277 282 5453 5458 I-lower_bound

Patients 0 8 5459 5467 O
with 9 13 5468 5472 O
uncontrolled 14 26 5473 5485 O
seizures 27 35 5486 5494 B-chronic_disease

Platelet 0 8 5495 5503 B-clinical_variable
count 9 14 5504 5509 I-clinical_variable
( 15 16 5510 5511 I-clinical_variable
PLT 16 19 5511 5514 I-clinical_variable
) 19 20 5514 5515 I-clinical_variable
< 21 22 5516 5517 O
100,000 23 30 5518 5525 B-upper_bound
/ 30 31 5525 5526 I-upper_bound
μl 31 33 5526 5528 I-upper_bound

Platelets 0 9 5529 5538 B-clinical_variable
≥ 10 11 5539 5540 O
100,000 12 19 5541 5548 B-lower_bound
/ 19 20 5548 5549 I-lower_bound
μL 20 22 5549 5551 I-lower_bound

Prior 0 5 5552 5557 B-treatment
experimental 6 18 5558 5570 I-treatment
( 19 20 5571 5572 I-treatment
non 20 23 5572 5575 I-treatment
- 23 24 5575 5576 I-treatment
FDA 24 27 5576 5579 I-treatment
approved 28 36 5580 5588 I-treatment
) 36 37 5588 5589 I-treatment
therapies 38 47 5590 5599 I-treatment
and 48 51 5600 5603 I-treatment
immunotherapies 52 67 5604 5619 I-treatment

Prior 0 5 5620 5625 B-treatment
radiation 6 15 5626 5635 I-treatment
therapy 16 23 5636 5643 I-treatment
is 24 26 5644 5646 O
allowed 27 34 5647 5654 O
. 34 35 5654 5655 O
Patients 36 44 5656 5664 O
must 45 49 5665 5669 O
not 50 53 5670 5673 O
have 54 58 5674 5678 O
received 59 67 5679 5687 O
radiation 68 77 5688 5697 O
therapy 78 85 5698 5705 O
within 86 92 5706 5712 O
21 93 95 5713 5715 B-upper_bound
days 96 100 5716 5720 I-upper_bound
prior 101 106 5721 5726 I-upper_bound
to 107 109 5727 5729 O
the 110 113 5730 5733 O
initiation 114 124 5734 5744 O
of 125 127 5745 5747 O
study 128 133 5748 5753 O
treatment 134 143 5754 5763 B-treatment

Prior 0 5 5764 5769 O
standard 6 14 5770 5778 O
of 15 17 5779 5781 O
care 18 22 5782 5786 O
cancer 23 29 5787 5793 B-treatment
chemotherapy 30 42 5794 5806 I-treatment
, 42 43 5806 5807 O
immunotherapy 44 57 5808 5821 B-treatment
, 57 58 5821 5822 O
or 59 61 5823 5825 O
radiotherapy 62 74 5826 5838 B-treatment
< 75 76 5839 5840 O
21 76 78 5840 5842 B-upper_bound
days 79 83 5843 5847 I-upper_bound
prior 84 89 5848 5853 I-upper_bound
to 90 92 5854 5856 O
first 93 98 5857 5862 O
dose 99 103 5863 5867 O
of 104 106 5868 5870 O
study 107 112 5871 5876 B-treatment
agent(s 113 120 5877 5884 I-treatment
) 120 121 5884 5885 I-treatment

Progressive 0 11 5886 5897 O
cancer 12 18 5898 5904 B-cancer
at 19 21 5905 5907 O
the 22 25 5908 5911 O
time 26 30 5912 5916 O
of 31 33 5917 5919 O
study 34 39 5920 5925 O
entry 40 45 5926 5931 O

Psychological 0 13 5932 5945 B-chronic_disease
, 13 14 5945 5946 O
familial 15 23 5947 5955 B-chronic_disease
, 23 24 5955 5956 O
sociological 25 37 5957 5969 O
, 37 38 5969 5970 O
or 39 41 5971 5973 O
geographical 42 54 5974 5986 O
conditions 55 65 5987 5997 O
that 66 70 5998 6002 O
do 71 73 6003 6005 O
not 74 77 6006 6009 O
permit 78 84 6010 6016 O
compliance 85 95 6017 6027 O
with 96 100 6028 6032 O
the 101 104 6033 6036 O
protocol 105 113 6037 6045 O

Refractory 0 10 6046 6056 O
nausea 11 17 6057 6063 O
and 18 21 6064 6067 O
vomiting 22 30 6068 6076 O
, 30 31 6076 6077 O
chronic 32 39 6078 6085 O
gastrointestinal 40 56 6086 6102 B-chronic_disease
diseases 57 65 6103 6111 I-chronic_disease
( 66 67 6112 6113 O
e.g. 67 71 6113 6117 O
inflammatory 72 84 6118 6130 B-chronic_disease
bowel 85 90 6131 6136 I-chronic_disease
disease 91 98 6137 6144 I-chronic_disease
) 98 99 6144 6145 O
or 100 102 6146 6148 O
significant 103 114 6149 6160 O
bowel 115 120 6161 6166 B-treatment
resection 121 130 6167 6176 I-treatment
that 131 135 6177 6181 O
would 136 141 6182 6187 O
preclude 142 150 6188 6196 O
adequate 151 159 6197 6205 O
absorption 160 170 6206 6216 O

Serum 0 5 6217 6222 B-clinical_variable
creatinine 6 16 6223 6233 I-clinical_variable
≤ 17 18 6234 6235 O
1.5 19 22 6236 6239 B-upper_bound
ULN 23 26 6240 6243 I-upper_bound

Total 0 5 6244 6249 B-clinical_variable
bilirubin 6 15 6250 6259 I-clinical_variable
≤ 16 17 6260 6261 O
1.5 18 21 6262 6265 B-upper_bound
×ULN 22 26 6266 6270 I-upper_bound

WBC 0 3 6271 6274 B-clinical_variable
≤ 4 5 6275 6276 O
3x109 6 11 6277 6282 B-upper_bound
/ 11 12 6282 6283 I-upper_bound
L 12 13 6283 6284 I-upper_bound

White 0 5 6285 6290 B-clinical_variable
blood 6 11 6291 6296 I-clinical_variable
cells 12 17 6297 6302 I-clinical_variable
( 18 19 6303 6304 I-clinical_variable
WBC 19 22 6304 6307 I-clinical_variable
) 22 23 6307 6308 I-clinical_variable
> 24 25 6309 6310 O
3x109 26 31 6311 6316 B-lower_bound
/ 31 32 6316 6317 I-lower_bound
L 32 33 6317 6318 I-lower_bound

Whole 0 5 6319 6324 B-treatment
blood 6 11 6325 6330 I-treatment
transfusion 12 23 6331 6342 I-treatment
in 24 26 6343 6345 O
the 27 30 6346 6349 O
last 31 35 6350 6354 O
120 36 39 6355 6358 B-upper_bound
days 40 44 6359 6363 I-upper_bound
prior 45 50 6364 6369 I-upper_bound
to 51 53 6370 6372 O
entry 54 59 6373 6378 O
to 60 62 6379 6381 O
the 63 66 6382 6385 O
study 67 72 6386 6391 O

Women 0 5 6392 6397 B-gender
of 6 8 6398 6400 O
child 9 14 6401 6406 O
- 14 15 6406 6407 O
bearing 15 22 6407 6414 O
potential 23 32 6415 6424 O
must 33 37 6425 6429 O
have 38 42 6430 6434 O
a 43 44 6435 6436 O
negative 45 53 6437 6445 B-pregnancy
pregnancy 54 63 6446 6455 I-pregnancy
test 64 68 6456 6460 O
( 69 70 6461 6462 O
urine 70 75 6462 6467 O
or 76 78 6468 6470 O
serum 79 84 6471 6476 O
) 84 85 6476 6477 O
within 86 92 6478 6484 O
28 93 95 6485 6487 B-upper_bound
days 96 100 6488 6492 I-upper_bound
prior 101 106 6493 6498 I-upper_bound
to 107 109 6499 6501 O
starting 110 118 6502 6510 O
the 119 122 6511 6514 O
study 123 128 6515 6520 B-treatment
drug 129 133 6521 6525 I-treatment

Women 0 5 6526 6531 B-gender
who 6 9 6532 6535 O
are 10 13 6536 6539 O
pregnant 14 22 6540 6548 B-pregnancy
or 23 25 6549 6551 O
lactating 26 35 6552 6561 O
( 36 37 6562 6563 O
breastfeeding 37 50 6563 6576 O
) 50 51 6576 6577 O

